Products

Signal Tracker Data Platform Data Enrichment API Intelligence desk

Solutions

Inward Investment & Aftercare Deal Origination Executive Search Corporate Development Signal-Based Outbound Competitive Intelligence Funding Signals Competitor Monitoring For Sales Teams For Founders For Agencies For Investors

Explore

Companies Live Signals Markets Trends

Resources

Signal Checker Blog Integrations FAQ Contact Pricing
Login Book a demo
Avobis Bio logo — Implantable cell therapies for healing debilitating conditio...

Avobis Bio

Implantable cell therapies for healing debilitating conditions

Founded 2019 10 employees Biotechnology, Health Care

General Information

Company Name Avobis Bio
Founded Year 2019
Founders / Decision Makers
Team member
Employees 10
Industries Biotechnology, Health Care
Social

Get notified when Avobis Bio moves

Funding, new markets, leadership changes, hiring surges — one e-mail, only when something happens.

Free · no account needed

About Avobis Bio

Avobis Bio is a biotechnology and healthcare startup founded in 2019, dedicated to developing implantable cell therapies for debilitating conditions. The company's investigational portfolio focuses on utilizing mesenchymal stem cells combined with bioabsorbable scaffolds to enhance the cells' effectiveness in stimulating the body to heal. Avobis Bio is a joint venture between Mayo Clinic and W. L. Gore & Associates, leveraging a combination of clinical care, cell biology, materials science, and commercialization of medical products. The company's name, derived from the Latin a vobis, meaning "from you" or "by you," pays tribute to the patients it serves and the power of their own mesenchymal stem cells. With no publicly disclosed headquarter location or last investment details, Avobis Bio stands as an intriguing player in the evolving field of regenerative medicine.

Taxonomy: Implantable Cell Therapies, Mesenchymal Stem Cells, Bioabsorbable Scaffolds, Clinical Care, Cell Biology, Materials Science, Commercialization of Medical Products, Regenerative Medicine, Joint Venture, Medical Research

No funding data available for Avobis Bio yet.

Get notified when Avobis Bio raises funding

Avobis Bio Alternatives & Competitors

Avobis Bio vs
American Cell Technology
American Cell Technology United States

A leading stem cell banking provider focused on adult and newborn autologous Mesenchymal Stem Cells...

14 employees
Biotechnology, Life Sciences
Avobis Bio vs
Beilai Bio
Beilai Bio

Advancing the future of healthcare with stem cell therapeutics, converting medical waste into powerf...

Series B
Biotechnology
Avobis Bio vs
Kangstem Biotech Co., Ltd.
Kangstem Biotech Co., Ltd.

To become World Top Stem Cell Company, all executives and employees are preparing for a 'better tomo...

23 employees
Biotechnology, Health Care

FAQ About Avobis Bio

Implantable cell therapies for healing debilitating conditions
Avobis Bio was founded in 2019.
Avobis Bio operates in the following industries: Biotechnology, Health Care.
Avobis Bio has approximately 10 employees.
Top alternatives and competitors to Avobis Bio include American Cell Technology, Beilai Bio, Kangstem Biotech Co., Ltd., Medipost Co Ltd, Agulos Biotech LLC. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
Avobis Bio and American Cell Technology are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Don't just browse. Track.

Signal Tracker monitors Avobis Bio and millions of companies for funding rounds, hiring surges, product changes, and 40+ signal types — so you never miss an opportunity.

See how it works

One analytics cookie (Google Analytics). Cookie Policy